NCT05444582View on ClinicalTrials.gov

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,404

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

July 31, 2027

Conditions
Contraception
Interventions
DRUG

Levonorgestrel 52 MG Intrauterine System

"Eligible participants must be 16-35 years old, meet clinic eligibility for IUD placement, and having a LNG 52 mg IUD placed for either:~Emergency Contraception (had unprotected intercourse in the last 5 days) OR Same-day start - \>7 days since the onset of last menstrual period and have no report of unprotected intercourse in the last 5 days."

Trial Locations (8)

55114

ACTIVE_NOT_RECRUITING

Planned Parenthood North Central States, Saint Paul

60603

RECRUITING

Planned Parenthood Illinoi, Chicago

80207

RECRUITING

Planned Parenthood of the Rocky Mountains, Denver

84102

RECRUITING

Planned Parenthood Association of Utah, Salt Lake City

95126

RECRUITING

Planned Parenthood Mar Monte, San Jose

97212

RECRUITING

Planned Parenthood Columbia Willamette, Portland

98122

RECRUITING

Planned Parenthood Great Northwest Hawaii, Alaska, Indiana, Kentucky, Seattle

02215

RECRUITING

Planned Parenthood League of Massachusetts, Boston

All Listed Sponsors
collaborator

Planned Parenthood Federation of America

OTHER

lead

University of Utah

OTHER